25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

PGEN (Precigen) Stock Analysis
Buy, Hold or Sell?

Let's analyze Precigen together

I guess you are interested in Precigen Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Precigen’s Financial Insights
  • 📈 Technical Analysis (TA) – Precigen’s Price Targets

I'm going to help you getting a better view of Precigen Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Precigen Inc

I send you an email if I find something interesting about Precigen Inc.

1. Quick Overview

1.1. Quick analysis of Precigen (30 sec.)










1.2. What can you expect buying and holding a share of Precigen? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
15.0%

What is your share worth?

Current worth
$-0.05
Expected worth in 1 year
$-0.42
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
$-0.38
Return On Investment
-23.4%

For what price can you sell your share?

Current Price per Share
$1.61
Expected price per share
$1.28 - $1.96
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Precigen (5 min.)




Live pricePrice per Share (EOD)
$1.61
Intrinsic Value Per Share
$-2.40 - $-1.41
Total Value Per Share
$-2.45 - $-1.46

2.2. Growth of Precigen (5 min.)




Is Precigen growing?

Current yearPrevious yearGrowGrow %
How rich?-$14m$130m-$99.3m-323.0%

How much money is Precigen making?

Current yearPrevious yearGrowGrow %
Making money-$39.1m-$24.2m-$14.9m-38.1%
Net Profit Margin-4,102.9%-1,876.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Precigen (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#829 / 884

Most Revenue
#456 / 884

Most Profit
#752 / 884

Most Efficient
#804 / 884
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Precigen?

Welcome investor! Precigen's management wants to use your money to grow the business. In return you get a share of Precigen.

First you should know what it really means to hold a share of Precigen. And how you can make/lose money.

Speculation

The Price per Share of Precigen is $1.61. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Precigen.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Precigen, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.05. Based on the TTM, the Book Value Change Per Share is $-0.09 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.07 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Precigen.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.18-11.4%-0.13-8.2%-0.08-5.1%-0.06-4.0%-0.08-4.8%-0.15-9.2%
Usd Book Value Change Per Share-0.18-11.1%-0.09-5.8%-0.07-4.6%-0.02-1.5%-0.02-1.1%-0.06-3.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.010.8%
Usd Total Gains Per Share-0.18-11.1%-0.09-5.8%-0.07-4.5%-0.02-1.5%-0.02-1.1%-0.04-2.8%
Usd Price Per Share1.49-1.28-1.34-1.38-2.97-10.90-
Price to Earnings Ratio-2.03--2.78--4.24--3.37--8.02--21.85-
Price-to-Total Gains Ratio-8.37--3.43--21.81--11.47-3.28--65.01-
Price to Book Ratio-31.28--1.71-3.23-1.90-8.43-9.98-
Price-to-Total Gains Ratio-8.37--3.43--21.81--11.47-3.28--65.01-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.61
Number of shares621
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.09-0.02
Usd Total Gains Per Share-0.09-0.02
Gains per Quarter (621 shares)-58.42-10.58
Gains per Year (621 shares)-233.69-42.33
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-234-2440-43-52
20-467-4781-85-94
30-701-7121-128-136
40-935-9461-170-178
50-1168-11801-213-220
60-1402-14142-256-262
70-1636-16482-298-304
80-1870-18822-341-346
90-2103-21163-384-388
100-2337-23503-426-430

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%1.019.00.05.0%1.039.00.02.5%5.048.00.09.4%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%6.014.00.030.0%10.030.00.025.0%15.035.03.028.3%
Dividend per Share0.00.04.00.0%1.00.011.08.3%1.00.019.05.0%6.00.034.015.0%8.00.045.015.1%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%6.014.00.030.0%12.028.00.030.0%17.033.03.032.1%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Precigen Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.178-0.094-47%-0.074-59%-0.025-86%-0.017-90%-0.057-68%
Book Value Per Share---0.0480.104-146%0.441-111%0.325-115%0.334-114%0.988-105%
Current Ratio--3.5272.736+29%2.744+29%2.785+27%3.579-1%3.313+6%
Debt To Asset Ratio--1.1090.648+71%0.245+352%0.458+142%0.564+97%0.504+120%
Debt To Equity Ratio---0.993-100%0.320-100%0.989-100%1.861-100%1.489-100%
Dividend Per Share----0%0.001-100%0.000-100%0.000-100%0.012-100%
Enterprise Value--377213200.000358750044.500+5%422041950.000-11%393608764.833-4%811276348.900-54%3100239069.450-88%
Eps---0.183-0.133-28%-0.082-55%-0.065-65%-0.077-58%-0.149-19%
Ev To Ebitda Ratio---1.762-2.726+55%-4.897+178%-7.444+322%-12.699+621%-33.873+1822%
Ev To Sales Ratio--70.32392.592-24%80.800-13%69.226+2%47.477+48%38.992+80%
Free Cash Flow Per Share---0.057-0.064+11%-0.058+1%-0.060+4%-0.059+3%-0.078+36%
Free Cash Flow To Equity Per Share---0.0600.029-304%-0.070+18%-0.064+8%-0.041-31%-0.019-68%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0030%1.0030%
Intrinsic Value_10Y_max---1.414----------
Intrinsic Value_10Y_min---2.399----------
Intrinsic Value_1Y_max---0.225----------
Intrinsic Value_1Y_min---0.301----------
Intrinsic Value_3Y_max---0.613----------
Intrinsic Value_3Y_min---0.858----------
Intrinsic Value_5Y_max---0.924----------
Intrinsic Value_5Y_min---1.358----------
Market Cap475239800.000+7%439818200.000379092294.500+16%395541200.000+11%406785098.167+8%877379748.900-50%3217514394.450-86%
Net Profit Margin---40.383-41.029+2%-18.765-54%-22.314-45%-13.846-66%-7.883-80%
Operating Margin---40.382-41.632+3%-18.829-53%-22.900-43%-14.115-65%-7.793-81%
Operating Ratio--17.85037.995-53%18.276-2%21.889-18%13.891+29%8.104+120%
Pb Ratio-33.801-8%-31.282-1.711-95%3.227-1069%1.901-1745%8.430-471%9.983-413%
Pe Ratio-2.194-8%-2.030-2.780+37%-4.242+109%-3.367+66%-8.024+295%-21.854+976%
Price Per Share1.610+7%1.4901.284+16%1.340+11%1.378+8%2.972-50%10.900-86%
Price To Free Cash Flow Ratio-7.011-8%-6.488-5.737-12%-5.777-11%-6.248-4%-13.934+115%-25.506+293%
Price To Total Gains Ratio-9.040-8%-8.366-3.432-59%-21.806+161%-11.472+37%3.276-355%-65.007+677%
Quick Ratio--6.4834.292+51%4.510+44%4.077+59%5.049+28%4.366+48%
Return On Assets---0.420-0.412-2%-0.149-65%-0.182-57%-0.141-66%-0.117-72%
Return On Equity----0.5770%-0.1950%-0.2700%-0.3090%-0.2930%
Total Gains Per Share---0.178-0.094-47%-0.073-59%-0.025-86%-0.017-90%-0.044-75%
Usd Book Value---14060000.00030749750.000-146%130076500.000-111%95990166.667-115%98678600.000-114%291781575.000-105%
Usd Book Value Change Per Share---0.178-0.094-47%-0.074-59%-0.025-86%-0.017-90%-0.057-68%
Usd Book Value Per Share---0.0480.104-146%0.441-111%0.325-115%0.334-114%0.988-105%
Usd Dividend Per Share----0%0.001-100%0.000-100%0.000-100%0.012-100%
Usd Enterprise Value--377213200.000358750044.500+5%422041950.000-11%393608764.833-4%811276348.900-54%3100239069.450-88%
Usd Eps---0.183-0.133-28%-0.082-55%-0.065-65%-0.077-58%-0.149-19%
Usd Free Cash Flow---16947000.000-18815750.000+11%-17091250.000+1%-17648083.333+4%-17440500.000+3%-22976975.000+36%
Usd Free Cash Flow Per Share---0.057-0.064+11%-0.058+1%-0.060+4%-0.059+3%-0.078+36%
Usd Free Cash Flow To Equity Per Share---0.0600.029-304%-0.070+18%-0.064+8%-0.041-31%-0.019-68%
Usd Market Cap475239800.000+7%439818200.000379092294.500+16%395541200.000+11%406785098.167+8%877379748.900-50%3217514394.450-86%
Usd Price Per Share1.610+7%1.4901.284+16%1.340+11%1.378+8%2.972-50%10.900-86%
Usd Profit---54153000.000-39162500.000-28%-24227000.000-55%-19762333.333-64%-23154400.000-57%-44044725.000-19%
Usd Revenue--1341000.0001050250.000+28%1359750.000-1%2740583.333-51%12106050.000-89%27449550.000-95%
Usd Total Gains Per Share---0.178-0.094-47%-0.073-59%-0.025-86%-0.017-90%-0.044-75%
 EOD+6 -2MRQTTM+18 -18YOY+16 -223Y+17 -215Y+9 -3010Y+11 -28

3.3 Fundamental Score

Let's check the fundamental score of Precigen Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.194
Price to Book Ratio (EOD)Between0-1-33.801
Net Profit Margin (MRQ)Greater than0-40.383
Operating Margin (MRQ)Greater than0-40.382
Quick Ratio (MRQ)Greater than16.483
Current Ratio (MRQ)Greater than13.527
Debt to Asset Ratio (MRQ)Less than11.109
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.420
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Precigen Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.563
Ma 20Greater thanMa 501.469
Ma 50Greater thanMa 1001.442
Ma 100Greater thanMa 2001.555
OpenGreater thanClose1.450
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Precigen Inc

Precigen, Inc.,a discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases. It operates through two segments, Biopharmaceuticals and Exemplar. The company offers therapeutic platforms consisting of AdenoVerse platform, which utilizes a library of proprietary adenovectors for gene delivery of therapeutic effectors, immunomodulators, and vaccine antigen; and UltraCAR-T to provide chimeric antigen receptor T cell therapies for cancer patients. It also develops programs based on the UltraCAR-T platform, including PRGN-3005 in Phase 1b clinical trial to treat advanced ovarian, fallopian tube, or primary peritoneal cancer; PRGN-3006 in Phase 1b trial for patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndromes; and PRGN-3007 in Phase 1/1b trial for the treatment of advanced receptor tyrosine kinase-like orphan receptor 1-positive, hematologic, and solid tumors. In addition, the company is developing programs based on the AdenoVerse immunotherapy platform comprising PRGN-2009 in Phase 2 trial for patients with HPV+ solid tumors; PRGN-2012 in Phase ½ trial to treat recurrent respiratory papillomatosis; and AG019, which is in Phase 1b/2a trial, to treat type 1 diabetes mellitus. Further, it provides UltraPorator, a proprietary electroporation device; and develops research models and services for healthcare research applications. The company was formerly known as Intrexon Corporation and changed its name to Precigen, Inc. in February 2020. Precigen, Inc. was founded in 1998 and is headquartered in Germantown, Maryland.

Fundamental data was last updated by Penke on 2025-06-20 11:33:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Precigen earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Precigen to the Biotechnology industry mean.
  • A Net Profit Margin of -4,038.3% means that $-40.38 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Precigen Inc:

  • The MRQ is -4,038.3%. The company is making a huge loss. -2
  • The TTM is -4,102.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-4,038.3%TTM-4,102.9%+64.7%
TTM-4,102.9%YOY-1,876.5%-2,226.4%
TTM-4,102.9%5Y-1,384.6%-2,718.4%
5Y-1,384.6%10Y-788.3%-596.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-4,038.3%-92.7%-3,945.6%
TTM-4,102.9%-141.4%-3,961.5%
YOY-1,876.5%-186.1%-1,690.4%
3Y-2,231.4%-248.3%-1,983.1%
5Y-1,384.6%-338.6%-1,046.0%
10Y-788.3%-488.9%-299.4%
4.3.1.2. Return on Assets

Shows how efficient Precigen is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Precigen to the Biotechnology industry mean.
  • -42.0% Return on Assets means that Precigen generated $-0.42 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Precigen Inc:

  • The MRQ is -42.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -41.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-42.0%TTM-41.2%-0.9%
TTM-41.2%YOY-14.9%-26.3%
TTM-41.2%5Y-14.1%-27.1%
5Y-14.1%10Y-11.7%-2.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-42.0%-11.5%-30.5%
TTM-41.2%-11.6%-29.6%
YOY-14.9%-11.4%-3.5%
3Y-18.2%-11.8%-6.4%
5Y-14.1%-12.1%-2.0%
10Y-11.7%-13.8%+2.1%
4.3.1.3. Return on Equity

Shows how efficient Precigen is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Precigen to the Biotechnology industry mean.
  • 0.0% Return on Equity means Precigen generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Precigen Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-57.7%+57.7%
TTM-57.7%YOY-19.5%-38.2%
TTM-57.7%5Y-30.9%-26.7%
5Y-30.9%10Y-29.3%-1.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.6%+13.6%
TTM-57.7%-14.9%-42.8%
YOY-19.5%-14.4%-5.1%
3Y-27.0%-17.0%-10.0%
5Y-30.9%-17.9%-13.0%
10Y-29.3%-20.1%-9.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Precigen Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Precigen is operating .

  • Measures how much profit Precigen makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Precigen to the Biotechnology industry mean.
  • An Operating Margin of -4,038.2% means the company generated $-40.38  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Precigen Inc:

  • The MRQ is -4,038.2%. The company is operating very inefficient. -2
  • The TTM is -4,163.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-4,038.2%TTM-4,163.2%+125.0%
TTM-4,163.2%YOY-1,882.9%-2,280.3%
TTM-4,163.2%5Y-1,411.5%-2,751.7%
5Y-1,411.5%10Y-779.3%-632.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-4,038.2%-229.2%-3,809.0%
TTM-4,163.2%-250.3%-3,912.9%
YOY-1,882.9%-205.1%-1,677.8%
3Y-2,290.0%-220.2%-2,069.8%
5Y-1,411.5%-342.6%-1,068.9%
10Y-779.3%-475.5%-303.8%
4.3.2.2. Operating Ratio

Measures how efficient Precigen is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 17.85 means that the operating costs are $17.85 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Precigen Inc:

  • The MRQ is 17.850. The company is inefficient in keeping operating costs low. -1
  • The TTM is 37.995. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ17.850TTM37.995-20.145
TTM37.995YOY18.276+19.719
TTM37.9955Y13.891+24.104
5Y13.89110Y8.104+5.787
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ17.8502.110+15.740
TTM37.9952.704+35.291
YOY18.2763.063+15.213
3Y21.8893.576+18.313
5Y13.8914.713+9.178
10Y8.1046.512+1.592
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Precigen Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Precigen is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.53 means the company has $3.53 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Precigen Inc:

  • The MRQ is 3.527. The company is very able to pay all its short-term debts. +2
  • The TTM is 2.736. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ3.527TTM2.736+0.791
TTM2.736YOY2.744-0.008
TTM2.7365Y3.579-0.843
5Y3.57910Y3.313+0.266
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.5273.661-0.134
TTM2.7363.786-1.050
YOY2.7444.121-1.377
3Y2.7854.680-1.895
5Y3.5795.765-2.186
10Y3.3136.150-2.837
4.4.3.2. Quick Ratio

Measures if Precigen is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Precigen to the Biotechnology industry mean.
  • A Quick Ratio of 6.48 means the company can pay off $6.48 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Precigen Inc:

  • The MRQ is 6.483. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.292. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ6.483TTM4.292+2.190
TTM4.292YOY4.510-0.218
TTM4.2925Y5.049-0.757
5Y5.04910Y4.366+0.682
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.4832.826+3.657
TTM4.2923.128+1.164
YOY4.5103.782+0.728
3Y4.0774.304-0.227
5Y5.0495.703-0.654
10Y4.3666.454-2.088
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Precigen Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Precigen assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Precigen to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.11 means that Precigen assets are financed with 110.9% credit (debt) and the remaining percentage (100% - 110.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Precigen Inc:

  • The MRQ is 1.109. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 0.648. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ1.109TTM0.648+0.462
TTM0.648YOY0.245+0.402
TTM0.6485Y0.564+0.083
5Y0.56410Y0.504+0.060
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1090.324+0.785
TTM0.6480.347+0.301
YOY0.2450.327-0.082
3Y0.4580.339+0.119
5Y0.5640.349+0.215
10Y0.5040.382+0.122
4.5.4.2. Debt to Equity Ratio

Measures if Precigen is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Precigen to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Precigen Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.993-0.993
TTM0.993YOY0.320+0.673
TTM0.9935Y1.861-0.868
5Y1.86110Y1.489+0.372
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.383-0.383
TTM0.9930.436+0.557
YOY0.3200.410-0.090
3Y0.9890.446+0.543
5Y1.8610.460+1.401
10Y1.4890.509+0.980
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Precigen generates.

  • Above 15 is considered overpriced but always compare Precigen to the Biotechnology industry mean.
  • A PE ratio of -2.03 means the investor is paying $-2.03 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Precigen Inc:

  • The EOD is -2.194. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.030. Based on the earnings, the company is expensive. -2
  • The TTM is -2.780. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.194MRQ-2.030-0.164
MRQ-2.030TTM-2.780+0.749
TTM-2.780YOY-4.242+1.463
TTM-2.7805Y-8.024+5.244
5Y-8.02410Y-21.854+13.830
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.194-2.197+0.003
MRQ-2.030-2.027-0.003
TTM-2.780-2.527-0.253
YOY-4.242-3.733-0.509
3Y-3.367-3.717+0.350
5Y-8.024-6.036-1.988
10Y-21.854-6.649-15.205
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Precigen Inc:

  • The EOD is -7.011. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -6.488. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.737. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.011MRQ-6.488-0.523
MRQ-6.488TTM-5.737-0.751
TTM-5.737YOY-5.777+0.040
TTM-5.7375Y-13.934+8.197
5Y-13.93410Y-25.506+11.572
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-7.011-3.007-4.004
MRQ-6.488-2.704-3.784
TTM-5.737-3.627-2.110
YOY-5.777-4.334-1.443
3Y-6.248-5.070-1.178
5Y-13.934-8.532-5.402
10Y-25.506-9.305-16.201
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Precigen is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -31.28 means the investor is paying $-31.28 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Precigen Inc:

  • The EOD is -33.801. Based on the equity, the company is expensive. -2
  • The MRQ is -31.282. Based on the equity, the company is expensive. -2
  • The TTM is -1.711. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-33.801MRQ-31.282-2.519
MRQ-31.282TTM-1.711-29.570
TTM-1.711YOY3.227-4.938
TTM-1.7115Y8.430-10.141
5Y8.43010Y9.983-1.553
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-33.8011.921-35.722
MRQ-31.2821.843-33.125
TTM-1.7112.113-3.824
YOY3.2272.467+0.760
3Y1.9012.541-0.640
5Y8.4303.666+4.764
10Y9.9834.311+5.672
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Precigen Inc.

4.8.1. Institutions holding Precigen Inc

Institutions are holding 67.048% of the shares of Precigen Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31Patients Capital Management LLC5.88531.331117372301-508945-2.8463
2025-03-31Adage Capital Partners Gp LLC3.820.0311112760004105953.7789
2025-03-31BlackRock Inc3.64260.0003107522153755723.6194
2025-03-31Vanguard Group Inc2.97990.000287959594654685.5875
2025-03-31Iridian Asset Management LLC1.55362.1434585809-656113-12.5166
2025-03-31Geode Capital Management, LLC1.17880.000434796021797515.4472
2025-03-31Parkman Healthcare Partners LLC1.08120.564319134331913430
2025-03-31State Street Corp1.02920.00023038127641602.1574
2025-03-31Charles Schwab Investment Management Inc0.41220.00031216764-62098-4.8557
2025-03-31Northern Trust Corp0.38170.00031126576-42113-3.6034
2025-03-31Morgan Stanley - Brokerage Accounts0.350.00011033110-86501-7.726
2025-03-31JPMorgan Chase & Co0.27550.0001813310-31843-3.7677
2025-03-31Renaissance Technologies Corp0.26860.0018792803-274842-25.7428
2025-03-31CI Private Wealth LLC0.24210.001771469110072016.4047
2025-03-31LexAurum Advisors, LLC0.23220.1957685298-6246-0.9032
2025-03-31GMT Capital Corp0.22660.052966883000
2024-12-31Nuveen Asset Management, LLC0.18120.000253498300
2024-12-31D. E. Shaw & Co LP0.14390.0004424900-792731-65.1044
2024-12-31UBS Group AG0.14270.0001421240321716323.2547
2025-03-31Fore Capital, LLC0.13270.345139181100
Total 24.164.66971315672+2647893+3.7%

4.9.2. Funds holding Precigen Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31Patient Opportunity C4.60741.310113600000-800000-5.5556
2025-04-30Vanguard Total Stock Mkt Idx Inv1.84750.0005545356700
2025-05-31iShares Russell 2000 ETF1.14280.0072337335200
2025-04-30Vanguard Institutional Extnd Mkt Idx Tr0.77930.0035230043065380.285
2025-03-31Fidelity Small Cap Index0.45650.00831347353131540.9859
2025-05-31iShares Russell 2000 Value ETF0.37880.0138111803500
2025-05-31iShares Biotechnology ETF0.32160.025194922700
2025-05-31State St Russell Sm/Mid Cp® Indx SL Cl I0.29420.002886838700
2025-04-30Fidelity Extended Market Index0.28340.0036836447-7995-0.9468
2025-05-31Schwab US Small-Cap ETF™0.24510.0058723428-1924-0.2653
2025-04-30JPM Thematics Genetic Thrps C2 dist USD0.24080.3017710829-16353-2.2488
2025-04-30Vanguard Russell 2000 ETF0.22840.0089674185373005.8566
2025-05-31State St Russell Sm Cap® Indx SL Cl I0.15980.007247168800
2025-03-31Extended Equity Market Fund K0.1110.003732776610050.3076
2025-04-30Schwab Small Cap Index0.11060.008732660900
2025-03-31NT R2000 Index Fund - NL0.10960.0083323633-25698-7.3563
2025-03-31Patient Opportunity Equity0.10761.1166317664-11246-3.4192
2025-04-30Nuveen Equity Index R60.09950.00129361900
2025-04-30SPDR® Russell 2000 US Small Cap ETF0.09380.0122277015-27023-8.888
2025-04-30Fidelity Total Market Index0.09370.000427652800
Total 11.71142.849434569762-832242-2.4%

5.3. Insider Transactions

Insiders are holding 10.516% of the shares of Precigen Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-08-09Jeffrey Thomas PerezBUY588230.85
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2024-03-312024-06-302024-09-302024-12-312025-03-31
Total Stockholder Equity 97,019-53,84943,17012,20655,376-16,86338,513-52,573-14,060
Net Invested Capital  97,019-53,84943,17012,20655,376-16,86338,513-52,573-14,060



5.2. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets128,787
Total Liabilities142,847
Total Stockholder Equity-14,060
 As reported
Total Liabilities 142,847
Total Stockholder Equity+ -14,060
Total Assets = 128,787

Assets

Total Assets128,787
Total Current Assets84,601
Long-term Assets44,186
Total Current Assets
Cash And Cash Equivalents 6,058
Short-term Investments 74,184
Net Receivables 1,064
Other Current Assets 3,295
Total Current Assets  (as reported)84,601
Total Current Assets  (calculated)84,601
+/-0
Long-term Assets
Property Plant Equipment 19,644
Goodwill 19,139
Long Term Investments 750
Intangible Assets 4,136
Long-term Assets Other 517
Long-term Assets  (as reported)44,186
Long-term Assets  (calculated)44,186
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities23,986
Long-term Liabilities118,861
Total Stockholder Equity-14,060
Total Current Liabilities
Short-term Debt 928
Accounts payable 3,107
Other Current Liabilities 19,402
Total Current Liabilities  (as reported)23,986
Total Current Liabilities  (calculated)23,437
+/- 549
Long-term Liabilities
Capital Lease Obligations 5,417
Long-term Liabilities  (as reported)118,861
Long-term Liabilities  (calculated)5,417
+/- 113,444
Total Stockholder Equity
Retained Earnings -2,144,859
Accumulated Other Comprehensive Income 12
Other Stockholders Equity 2,130,787
Total Stockholder Equity (as reported)-14,060
Total Stockholder Equity (calculated)-14,060
+/-0
Other
Cash and Short Term Investments 80,242
Common Stock Shares Outstanding 293,880
Current Deferred Revenue549
Liabilities and Stockholders Equity 128,787
Net Debt -641
Net Invested Capital -14,060
Net Working Capital 60,615
Property Plant and Equipment Gross 42,824
Short Long Term Debt Total 5,417



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
> Total Assets 
0
0
0
151,646
199,685
283,451
474,198
469,472
547,808
500,537
538,500
576,272
819,987
792,939
989,887
982,046
962,428
1,031,112
1,005,588
949,068
915,928
933,986
898,261
846,851
895,666
825,151
980,415
716,177
709,864
655,188
604,905
455,763
404,672
361,715
336,186
314,587
406,984
402,573
376,899
359,856
335,568
321,224
259,245
215,977
241,546
207,527
190,688
151,043
134,847
73,160
83,474
145,266
128,787
128,787145,26683,47473,160134,847151,043190,688207,527241,546215,977259,245321,224335,568359,856376,899402,573406,984314,587336,186361,715404,672455,763604,905655,188709,864716,177980,415825,151895,666846,851898,261933,986915,928949,0681,005,5881,031,112962,428982,046989,887792,939819,987576,272538,500500,537547,808469,472474,198283,451199,685151,646000
   > Total Current Assets 
0
0
0
13,533
66,014
134,318
206,235
187,556
232,932
188,303
181,304
174,773
238,799
359,538
302,431
323,801
336,539
345,657
316,223
315,181
281,670
234,117
179,740
154,047
187,545
147,814
310,470
285,483
232,175
183,164
157,332
234,643
189,383
172,995
151,116
148,948
144,118
156,685
153,092
156,628
154,937
164,619
162,806
118,159
137,743
105,632
92,988
68,755
49,546
23,715
34,513
102,414
84,601
84,601102,41434,51323,71549,54668,75592,988105,632137,743118,159162,806164,619154,937156,628153,092156,685144,118148,948151,116172,995189,383234,643157,332183,164232,175285,483310,470147,814187,545154,047179,740234,117281,670315,181316,223345,657336,539323,801302,431359,538238,799174,773181,304188,303232,932187,556206,235134,31866,01413,533000
       Cash And Cash Equivalents 
0
0
0
10,403
59,724
34,461
61,222
49,509
110,052
74,505
24,704
27,466
99,015
98,899
125,433
135,782
145,733
155,081
69,707
62,607
69,852
64,360
64,216
68,111
119,930
78,471
82,417
102,768
106,544
58,162
44,428
65,793
37,840
46,713
27,740
51,792
27,355
36,412
41,728
42,920
40,321
43,844
9,067
4,858
9,740
16,546
10,076
7,578
17,478
9,345
24,725
29,517
6,058
6,05829,51724,7259,34517,4787,57810,07616,5469,7404,8589,06743,84440,32142,92041,72836,41227,35551,79227,74046,71337,84065,79344,42858,162106,544102,76882,41778,471119,93068,11164,21664,36069,85262,60769,707155,081145,733135,782125,43398,89999,01527,46624,70474,505110,05249,50961,22234,46159,72410,403000
       Short-term Investments 
0
0
0
260
274
95,454
136,672
127,980
112,755
101,046
98,380
88,495
82,461
67,431
90,864
102,528
114,659
115,667
166,839
174,602
135,377
92,804
44,502
11,558
3,573
2,658
164,876
120,072
75,277
67,641
61,605
9,260
111,332
86,292
85,358
48,325
78,331
78,694
72,684
72,240
71,821
71,453
62,260
51,092
94,351
71,888
63,679
55,277
27,280
10,191
3,906
68,393
74,184
74,18468,3933,90610,19127,28055,27763,67971,88894,35151,09262,26071,45371,82172,24072,68478,69478,33148,32585,35886,292111,3329,26061,60567,64175,277120,072164,8762,6583,57311,55844,50292,804135,377174,602166,839115,667114,659102,52890,86467,43182,46188,49598,380101,046112,755127,980136,67295,454274260000
       Net Receivables 
0
0
0
472
735
1,305
5,349
145
7,419
9,808
26,940
29,264
27,079
160,730
55,866
52,294
37,893
43,716
42,219
42,485
43,201
43,637
38,253
39,841
30,719
33,822
30,307
28,078
24,881
34,457
24,971
26,228
19,628
23,995
19,360
20,427
21,357
26,671
21,083
21,471
24,866
1,871
2,454
13,804
15,522
14,406
14,105
1,575
1,162
1,016
729
1,163
1,064
1,0641,1637291,0161,1621,57514,10514,40615,52213,8042,4541,87124,86621,47121,08326,67121,35720,42719,36023,99519,62826,22824,97134,45724,88128,07830,30733,82230,71939,84138,25343,63743,20142,48542,21943,71637,89352,29455,866160,73027,07929,26426,9409,8087,4191455,3491,305735472000
       Other Current Assets 
0
0
0
2,163
2,255
3,098
2,992
2,710
2,706
2,944
14,606
3,759
4,073
5,477
7,930
6,634
13,176
6,701
15,578
14,348
14,157
14,170
15,039
14,044
13,052
12,790
14,576
21,469
5,577
4,712
9,033
117,271
5,947
3,266
8,310
17,045
6,438
3,484
7,661
13,233
5,199
47,227
88,806
48,118
4,330
2,792
5,128
4,325
3,626
3,163
5,153
3,341
3,295
3,2953,3415,1533,1633,6264,3255,1282,7924,33048,11888,80647,2275,19913,2337,6613,4846,43817,0458,3103,2665,947117,2719,0334,7125,57721,46914,57612,79013,05214,04415,03914,17014,15714,34815,5786,70113,1766,6347,9305,4774,0733,75914,6062,9442,7062,7102,9923,0982,2552,163000
   > Long-term Assets 
0
0
0
138,113
133,671
149,133
267,963
281,916
314,876
312,234
357,196
401,499
581,188
433,401
687,456
658,245
625,889
685,455
689,365
633,887
634,258
699,869
718,521
692,804
708,121
677,337
669,945
430,694
477,689
472,024
447,573
221,120
215,289
188,720
185,070
165,639
262,866
245,888
223,807
203,228
180,631
156,605
96,439
97,818
103,803
101,895
97,700
82,288
85,301
49,445
48,961
42,852
44,186
44,18642,85248,96149,44585,30182,28897,700101,895103,80397,81896,439156,605180,631203,228223,807245,888262,866165,639185,070188,720215,289221,120447,573472,024477,689430,694669,945677,337708,121692,804718,521699,869634,258633,887689,365685,455625,889658,245687,456433,401581,188401,499357,196312,234314,876281,916267,963149,133133,671138,113000
       Property Plant Equipment 
0
0
0
18,687
18,939
18,410
17,020
16,629
18,116
17,389
35,596
38,000
38,015
40,863
42,201
42,739
44,673
46,659
54,429
64,672
61,233
84,222
93,335
112,674
107,044
103,411
107,245
128,874
162,777
161,959
144,322
86,197
83,663
62,052
63,981
44,277
41,443
44,071
43,554
45,215
43,593
16,621
16,322
15,292
14,525
14,059
14,179
14,208
19,278
19,001
18,753
18,799
19,644
19,64418,79918,75319,00119,27814,20814,17914,05914,52515,29216,32216,62143,59345,21543,55444,07141,44344,27763,98162,05283,66386,197144,322161,959162,777128,874107,245103,411107,044112,67493,33584,22261,23364,67254,42946,65944,67342,73942,20140,86338,01538,00035,59617,38918,11616,62917,02018,41018,93918,687000
       Goodwill 
0
0
0
0
13,846
13,846
13,846
13,823
39,689
34,865
98,778
101,059
104,045
118,965
166,866
165,169
164,575
161,257
159,793
157,175
157,825
164,931
166,821
153,289
154,748
151,666
151,276
149,585
150,755
149,916
147,949
63,754
63,703
54,122
54,237
54,363
54,238
54,273
54,206
54,148
53,613
36,864
36,713
36,923
36,966
36,966
36,894
26,612
26,555
24,918
24,918
19,139
19,139
19,13919,13924,91824,91826,55526,61236,89436,96636,96636,92336,71336,86453,61354,14854,20654,27354,23854,36354,23754,12263,70363,754147,949149,916150,755149,585151,276151,666154,748153,289166,821164,931157,825157,175159,793161,257164,575165,169166,866118,965104,045101,05998,77834,86539,68913,82313,84613,84613,8460000
       Long Term Investments 
0
0
0
0
0
0
0
0
40,212
73,545
149,194
195,222
0
101,896
212,889
199,077
136,906
89,483
0
53,170
21,476
23,901
26,642
28,685
10,745
9,624
0
18,859
19,229
39,596
24,002
1,461
1,108
859
337
0
103,610
85,269
66,926
48,562
29,914
11,877
0
0
7,460
7,127
5,271
0
0
0
0
0
750
750000005,2717,1277,4600011,87729,91448,56266,92685,269103,61003378591,1081,46124,00239,59619,22918,85909,62410,74528,68526,64223,90121,47653,170089,483136,906199,077212,889101,8960195,222149,19473,54540,21200000000
       Intangible Assets 
0
0
0
29,506
43,681
42,972
42,263
41,956
41,269
45,406
68,216
65,947
129,308
162,234
256,284
247,535
255,460
244,314
238,581
225,615
223,074
240,360
240,897
232,877
231,883
218,838
213,244
129,291
125,868
112,526
107,141
68,346
65,489
64,759
65,018
65,396
61,230
59,942
56,914
54,115
51,427
45,933
42,416
44,455
43,848
42,656
40,426
40,701
38,717
5,091
4,773
4,455
4,136
4,1364,4554,7735,09138,71740,70140,42642,65643,84844,45542,41645,93351,42754,11556,91459,94261,23065,39665,01864,75965,48968,346107,141112,526125,868129,291213,244218,838231,883232,877240,897240,360223,074225,615238,581244,314255,460247,535256,284162,234129,30865,94768,21645,40641,26941,95642,26342,97243,68129,506000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,976
2,381
7,652
1,921
1,362
1,326
1,341
1,497
10,956
1,433
1,332
1,239
1,188
1,131
45,261
871
1,025
0
949
0
0
0
0
0
0
1,271
1,27100000094901,02587145,2611,1311,1881,2391,3321,43310,9561,4971,3411,3261,3621,9217,6522,3811,976000000000000000000000000000
> Total Liabilities 
0
0
0
473,199
71,941
644,975
82,990
88,129
115,910
112,171
158,658
166,983
166,642
306,012
260,264
277,160
287,596
402,931
397,168
379,820
365,767
362,436
345,082
300,306
324,240
258,010
424,972
337,455
375,041
375,965
376,484
384,052
317,443
312,173
277,634
247,413
232,189
243,377
245,652
252,508
261,732
265,571
116,713
89,718
57,413
41,317
43,010
41,644
37,828
29,990
28,098
106,753
142,847
142,847106,75328,09829,99037,82841,64443,01041,31757,41389,718116,713265,571261,732252,508245,652243,377232,189247,413277,634312,173317,443384,052376,484375,965375,041337,455424,972258,010324,240300,306345,082362,436365,767379,820397,168402,931287,596277,160260,264306,012166,642166,983158,658112,171115,91088,12982,990644,97571,941473,199000
   > Total Current Liabilities 
0
0
0
16,717
17,503
17,511
19,717
19,829
22,212
20,692
39,263
47,482
48,703
122,807
77,093
75,904
77,937
95,499
100,521
94,605
90,650
95,686
87,796
80,173
86,854
83,245
92,330
61,562
59,422
51,633
81,955
122,912
70,637
64,100
30,661
42,127
25,243
28,869
28,989
34,645
25,601
29,901
104,864
78,645
46,733
30,773
32,875
22,985
28,774
23,023
21,216
21,518
23,986
23,98621,51821,21623,02328,77422,98532,87530,77346,73378,645104,86429,90125,60134,64528,98928,86925,24342,12730,66164,10070,637122,91281,95551,63359,42261,56292,33083,24586,85480,17387,79695,68690,65094,605100,52195,49977,93775,90477,093122,80748,70347,48239,26320,69222,21219,82919,71717,51117,50316,717000
       Short-term Debt 
0
0
0
49
89
255
244
30
0
0
2,046
3,948
2,047
2,300
1,789
1,491
1,429
952
1,020
1,206
798
719
673
735
822
1,063
746
2,472
5,619
5,668
38,226
36,226
37,399
41,136
9,589
5,674
5,675
2,293
4,273
3,346
3,535
1,033
84,151
44,428
16,307
1,421
2,400
1,202
1,318
2,538
988
956
928
9289569882,5381,3181,2022,4001,42116,30744,42884,1511,0333,5353,3464,2732,2935,6755,6749,58941,13637,39936,22638,2265,6685,6192,4727461,0638227356737197981,2061,0209521,4291,4911,7892,3002,0473,9482,04600302442558949000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
559
841
855
32,002
33,592
33,091
32,108
421
360
359
356
355
402
355
0
82,069
43,219
13,819
0
0
0
0
0
0
0
0
0000000013,81943,21982,069035540235535635936042132,10833,09133,59232,002855841559000000000000000000000000000
       Accounts payable 
0
0
0
632
704
1,486
949
1,057
1,973
1,799
3,575
6,267
6,904
7,322
4,546
4,967
7,537
8,204
7,866
8,478
7,950
8,221
7,852
8,701
7,842
8,444
8,522
11,973
12,601
8,563
7,395
5,528
4,777
3,650
4,233
4,598
4,295
4,937
3,624
3,112
4,415
2,668
4,201
4,068
3,809
2,510
2,351
1,726
4,716
4,846
4,320
3,531
3,107
3,1073,5314,3204,8464,7161,7262,3512,5103,8094,0684,2012,6684,4153,1123,6244,9374,2954,5984,2333,6504,7775,5287,3958,56312,60111,9738,5228,4447,8428,7017,8528,2217,9508,4787,8668,2047,5374,9674,5467,3226,9046,2673,5751,7991,9731,0579491,486704632000
       Other Current Liabilities 
0
0
0
6,073
6,824
7,500
11,126
10,949
9,300
8,187
19,692
20,745
22,463
84,448
38,752
34,080
31,276
32,480
36,698
31,557
31,569
39,084
30,982
27,867
29,544
33,918
45,026
31,563
24,053
20,809
23,570
75,461
17,320
12,722
12,695
29,055
11,428
18,363
17,399
23,745
14,982
26,036
16,436
30,124
26,602
26,827
27,615
19,548
22,333
15,261
15,501
16,442
19,402
19,40216,44215,50115,26122,33319,54827,61526,82726,60230,12416,43626,03614,98223,74517,39918,36311,42829,05512,69512,72217,32075,46123,57020,80924,05331,56345,02633,91829,54427,86730,98239,08431,56931,55736,69832,48031,27634,08038,75284,44822,46320,74519,6928,1879,30010,94911,1267,5006,8246,073000
   > Long-term Liabilities 
0
0
0
456,482
54,438
627,464
63,273
68,300
93,698
91,479
119,395
119,501
117,939
183,205
183,171
201,256
209,659
307,432
296,647
285,215
275,117
266,750
257,286
220,133
237,386
174,765
332,642
275,893
315,619
324,332
294,529
261,140
246,806
248,073
246,973
205,286
206,946
214,508
216,663
217,863
236,131
235,670
11,849
11,073
10,680
10,544
10,135
18,659
9,054
6,967
6,882
85,235
118,861
118,86185,2356,8826,9679,05418,65910,13510,54410,68011,07311,849235,670236,131217,863216,663214,508206,946205,286246,973248,073246,806261,140294,529324,332315,619275,893332,642174,765237,386220,133257,286266,750275,117285,215296,647307,432209,659201,256183,171183,205117,939119,501119,39591,47993,69868,30063,273627,46454,438456,482000
       Long term Debt Total 
0
0
0
0
0
0
0
0
1,784
2,001
9,428
8,694
0
8,040
7,796
7,598
7,613
7,530
0
7,562
7,608
7,684
7,673
7,535
7,425
7,273
183,133
211,235
214,010
212,479
184,034
186,321
188,730
191,205
0
171,522
174,158
176,922
179,817
182,749
201,112
0
0
0
0
0
0
0
0
0
0
0
0
000000000000201,112182,749179,817176,922174,158171,5220191,205188,730186,321184,034212,479214,010211,235183,1337,2737,4257,5357,6737,6847,6087,56207,5307,6137,5987,7968,04008,6949,4282,0011,78400000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
64,658
61,424
73,096
72,313
50,970
35,662
35,656
32,849
26,020
25,845
25,765
25,647
25,612
25,511
28,898
3,910
4,081
0
3,999
0
0
0
0
0
0
0
00000003,99904,0813,91028,89825,51125,61225,64725,76525,84526,02032,84935,65635,66250,97072,31373,09661,42464,658000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
91,041
88,747
109,342
110,108
0
174,278
174,508
192,863
199,016
296,745
0
273,785
263,462
253,922
243,866
209,147
173,949
164,320
9,363
7,213
6,720
6,332
5,732
2,834
2,785
2,698
0
2,897
2,722
2,692
2,574
2,539
2,438
0
0
0
2,239
2,181
0
0
0
0
0
0
0
00000002,1812,2390002,4382,5392,5742,6922,7222,89702,6982,7852,8345,7326,3326,7207,2139,363164,320173,949209,147243,866253,922263,462273,7850296,745199,016192,863174,508174,2780110,108109,34288,74791,04100000000
> Total Stockholder Equity
0
0
0
-321,553
112,666
-376,149
377,133
366,722
415,902
373,255
358,361
384,761
640,668
474,835
718,287
694,078
664,932
619,230
600,473
560,237
528,538
550,870
533,613
533,631
553,109
549,752
539,399
362,855
313,029
279,223
228,421
71,711
87,229
49,542
58,552
67,174
174,795
159,196
131,247
107,348
73,836
55,653
142,532
126,259
184,133
166,210
147,678
118,498
97,019
43,170
55,376
38,513
-14,060
-14,06038,51355,37643,17097,019118,498147,678166,210184,133126,259142,53255,65373,836107,348131,247159,196174,79567,17458,55249,54287,22971,711228,421279,223313,029362,855539,399549,752553,109533,631533,613550,870528,538560,237600,473619,230664,932694,078718,287474,835640,668384,761358,361373,255415,902366,722377,133-376,149112,666-321,553000
   Common Stock
0
0
0
0
0
-15,600
-490,501
386,611
0
0
0
0
0
0
0
0
0
0
0
580,071
0
0
0
580,071
0
0
0
-579
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000-579000580,071000580,07100000000000386,611-490,501-15,60000000
   Retained Earnings Total Equity0000000-1,911,620-1,891,301-1,868,567-1,846,391-1,933,770-1,916,135-1,915,556-1,890,522-1,860,758-1,840,708-1,823,3900-1,752,221-1,708,867-1,652,869-1,483,654-1,430,020-1,391,254-1,330,545-990,080-932,756-867,374-847,820-820,554-780,865-762,201-729,3410-656,222-607,158-542,729-510,015-471,8020-458,236-477,067-424,342-372,29900000000
   Accumulated Other Comprehensive Income 
0
0
0
-13,375
-9
14
28
52
144
81
98
-4
-3,137
-2,285
-5,195
-12,752
-11,435
-21,651
-25,302
-36,202
-32,967
-24,221
-16,750
-15,554
-9,587
-21,848
-22,900
-28,612
-28,325
-28,206
-33,102
-27,468
-1,354
-650
1,362
3,997
1,746
2,541
1,515
203
-1,699
-4,556
-7,181
-3,488
-2,699
-2,518
-3,561
-3,894
-2,797
-2,909
13
12
12
121213-2,909-2,797-3,894-3,561-2,518-2,699-3,488-7,181-4,556-1,6992031,5152,5411,7463,9971,362-650-1,354-27,468-33,102-28,206-28,325-28,612-22,900-21,848-9,587-15,554-16,750-24,221-32,967-36,202-25,302-21,651-11,435-12,752-5,195-2,285-3,137-49881144522814-9-13,375000
   Capital Surplus 
0
0
0
0
0
0
0
0
788,057
797,516
835,330
843,001
0
948,922
1,233,497
1,249,559
1,283,525
1,297,103
0
1,325,780
1,323,706
1,355,956
1,370,917
1,397,005
1,492,916
1,504,356
1,552,379
1,722,012
1,732,608
1,737,449
1,745,177
1,752,048
1,797,450
1,802,413
0
1,886,567
2,013,757
2,017,413
2,020,254
2,022,701
1,991,670
1,993,979
1,996,104
1,998,314
2,078,133
2,080,348
0
0
0
0
0
0
0
00000002,080,3482,078,1331,998,3141,996,1041,993,9791,991,6702,022,7012,020,2542,017,4132,013,7571,886,56701,802,4131,797,4501,752,0481,745,1771,737,4491,732,6081,722,0121,552,3791,504,3561,492,9161,397,0051,370,9171,355,9561,323,7061,325,78001,297,1031,283,5251,249,5591,233,497948,9220843,001835,330797,516788,05700000000
   Treasury Stock00000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
-406,659
476,146
-567,858
741,315
743,084
788,057
797,516
835,330
843,001
1,074,944
948,922
1,233,497
1,249,559
1,283,525
1,297,103
1,310,979
1,325,780
1,323,706
1,355,956
1,370,917
1,397,005
1,492,916
1,504,356
1,552,379
1,722,012
1,732,608
1,737,449
1,745,177
1,752,048
1,797,450
1,802,413
1,838,919
1,886,567
2,013,757
2,017,413
2,020,254
2,022,701
1,991,670
1,993,979
1,996,104
1,998,314
2,078,133
2,080,348
2,082,654
2,084,916
2,088,025
2,093,080
2,126,342
2,129,207
2,130,787
2,130,7872,129,2072,126,3422,093,0802,088,0252,084,9162,082,6542,080,3482,078,1331,998,3141,996,1041,993,9791,991,6702,022,7012,020,2542,017,4132,013,7571,886,5671,838,9191,802,4131,797,4501,752,0481,745,1771,737,4491,732,6081,722,0121,552,3791,504,3561,492,9161,397,0051,370,9171,355,9561,323,7061,325,7801,310,9791,297,1031,283,5251,249,5591,233,497948,9221,074,944843,001835,330797,516788,057743,084741,315-567,858476,146-406,659000



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue3,925
Cost of Revenue-4,267
Gross Profit-342-342
 
Operating Income (+$)
Gross Profit-342
Operating Expense-134,687
Operating Income-135,029-135,029
 
Operating Expense (+$)
Research Development53,070
Selling General Administrative41,293
Selling And Marketing Expenses0
Operating Expense134,68794,363
 
Net Interest Income (+$)
Interest Income1,418
Interest Expense-6
Other Finance Cost-0
Net Interest Income1,412
 
Pretax Income (+$)
Operating Income-135,029
Net Interest Income1,412
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-128,028-142,030
EBIT - interestExpense = -128,028
-128,028
-126,229
Interest Expense6
Earnings Before Interest and Taxes (EBIT)-128,022-128,022
Earnings Before Interest and Taxes (EBITDA)-123,496
 
After tax Income (+$)
Income Before Tax-128,028
Tax Provision--1,793
Net Income From Continuing Ops-126,235-126,235
Net Income-126,235
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses138,954
Total Other Income/Expenses Net7,001-1,412
 

Technical Analysis of Precigen
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Precigen. The general trend of Precigen is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Precigen's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Precigen Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Precigen Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 1.65 < 1.655 < 1.96.

The bearish price targets are: 1.605 > 1.38 > 1.28.

Know someone who trades $PGEN? Share this with them.👇

Precigen Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Precigen Inc. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Precigen Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Precigen Inc. The current macd is 0.01697429.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Precigen price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Precigen. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Precigen price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Precigen Inc Daily Moving Average Convergence/Divergence (MACD) ChartPrecigen Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Precigen Inc. The current adx is 11.39.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Precigen shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Precigen Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Precigen Inc. The current sar is 1.39.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Precigen Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Precigen Inc. The current rsi is 62.56. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Precigen Inc Daily Relative Strength Index (RSI) ChartPrecigen Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Precigen Inc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Precigen price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Precigen Inc Daily Stochastic Oscillator ChartPrecigen Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Precigen Inc. The current cci is 158.72.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Precigen Inc Daily Commodity Channel Index (CCI) ChartPrecigen Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Precigen Inc. The current cmo is 37.63.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Precigen Inc Daily Chande Momentum Oscillator (CMO) ChartPrecigen Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Precigen Inc. The current willr is -27.71841609.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Precigen is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Precigen Inc Daily Williams %R ChartPrecigen Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Precigen Inc.

Precigen Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Precigen Inc. The current atr is 0.11127536.

Precigen Inc Daily Average True Range (ATR) ChartPrecigen Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Precigen Inc. The current obv is 51,744,021.

Precigen Inc Daily On-Balance Volume (OBV) ChartPrecigen Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Precigen Inc. The current mfi is 62.58.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Precigen Inc Daily Money Flow Index (MFI) ChartPrecigen Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Precigen Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-20STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-02-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-02-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-02-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-23CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-04-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-05-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-06-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-06-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Precigen Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Precigen Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.563
Ma 20Greater thanMa 501.469
Ma 50Greater thanMa 1001.442
Ma 100Greater thanMa 2001.555
OpenGreater thanClose1.450
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Precigen with someone you think should read this too:
  • Are you bullish or bearish on Precigen? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Precigen? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Precigen Inc

I send you an email if I find something interesting about Precigen Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Precigen Inc.

Receive notifications about Precigen Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.